|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
LITHIUM
Test CodeLAB29
CPT Codes
80178
Preferred Specimen
7 mL Red Top Tube
Minimum Volume
1.0 mL
Transport Temperature
Refrigerate
Methodology
Colorimetric
Setup Schedule
Set Up:Daily Report Available:1 day
Reference Range
Therapeutic: 0.6 - 1.2 mmol/L Critical value: >1.5 mmol/L |
Clinical Significance
Lithium, administered as lithium carbonate, is used for the treatment of the manic phase of affective disorder, mania and manic-depressive illness. It acts by enhancing reuptake of neurotransmitters, thereby decreasing their concentration in the neuronal junction. This produces a sedating effect on the central nervous system. Absorption of lithium from the gastrointestinal tract is complete, with peak plasma concentration reached from 2 to 4 hours after an oral dose. Clearance is predominately a function of the kidneys, where active reabsorption occurs. Early symptoms of lithium intoxication include apathy, sluggishness, drowsiness, lethargy, speech difficulty, irregular tremors, myoclonic twitchings, muscle weakness and ataxia.
Performing Laboratory
GBMC Chemistry